News & Articles

Parties to collaborate on development, commercialization, and supply of the Orgenesis therapies pipeline

Explore topics such as rapid antimicrobial resistance testing and analysis of viral vectors to Raman spectroscopy and high-performance thin-layer chromatography

The kit is ideally suited to NGS library preparation from a low input, patient-derived sample types, such as nasal swabs

Join us on Thursday, December 10, to discover how to rapidly diagnose antimicrobial resistance for appropriate therapy

Watch this on-demand webinar to learn how COVID immune responses can be assessed using a novel microfluidic in-solution immunoassay platform

Researchers recommend that targeted nutrition should be urgently explored as a counter-measure to mitochondrial damage

Designed to enrich pathologists' skills in biomarker interpretation and scoring techniques

The assay is developed for use in detection, characterisation, and monitoring of the SARS-CoV-2 virus

Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection

Two different dosing regimens demonstrated efficacy with one showing a better profile

The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic

Observations of rapid recovery on chest x-rays noted and no drug-related Serious Adverse Events reported

The new lots further enhance Lonza’s renowned human primary cell offerings as it looks to meet growing market demand for deeper cell characterization

Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing

QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes

Phase 3 part of clinical trial to enrol over 30,000 volunteers worldwide

The kit promises to be a low cost, high-sensitivity diagnostic test for COVID-19 detection

The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR

Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and vaccine development

Study enrolled 43,538 participants, with 42% having diverse backgrounds, and no serious safety concerns have been observed; Safety and additional efficacy data continue to be collected

The microscope aims to give microbiologists a greater insight into how single bio-molecules behave